EC-MPS, MMF Similar in Efficacy in Tacrolimus-Treated Transplant Patients Renal and Urology News ... showed that patients treated with EC-MPS or MMF had no significant differences with respect to concomitant immunosuppression, the incidence of biopsy-proven acute rejection at one year (9.6% for EC-MPS and 8.0% for MMF), graft survival at one year ... |
